eriodictyol has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, T; Lv, P; Xu, F; Xu, X; Yu, J | 1 |
| Bucolo, C; Drago, F; Leggio, GM; Salomone, S | 1 |
2 other study(ies) available for eriodictyol and Diabetic Retinopathy
| Article | Year |
|---|---|
Eriodictyol inhibits high glucose-induced oxidative stress and inflammation in retinal ganglial cells.
Topics: Animals; Cell Line; Diabetic Retinopathy; Dose-Response Relationship, Drug; Flavanones; Glucose; Inflammation; Oxidative Stress; Rats; Retinal Ganglion Cells | 2019 |
Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Blood-Retinal Barrier; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dose-Response Relationship, Drug; Flavanones; Lipid Peroxidation; Lipid Peroxides; Male; Molecular Structure; Oxidative Stress; Rats; Rats, Sprague-Dawley; Retina | 2012 |